US to still pay nearly twice as much after negotiating drug prices

WASHINGTON, D.C.: Despite the U.S. government's efforts to negotiate lower prescription drug prices under the Inflation Reduction Act, Medicare will still pay more than twice as much as other high-income countries for many medications.

According to a Reuters analysis, the newly set maximum prices for ten high-cost drugs are still significantly higher than those agreed upon in countries like Australia, Japan, Ca